Oxford Nanopore Technologies (LON:ONT) Trading Down 7.8% – Here’s What Happened

Oxford Nanopore Technologies plc (LON:ONT)’s stock price fell 7.8% on Monday . The company traded as low as GBX 131 ($1.65) and last traded at GBX 132 ($1.66). 3,102,731 shares traded hands during trading, an increase of 42% from the average session volume of 2,181,523 shares. The stock had previously closed at GBX 143.10 ($1.80).

Wall Street Analyst Weigh In

ONT has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 190 ($2.39) price target on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Berenberg Bank restated a “buy” rating and set a GBX 282 ($3.54) target price on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of GBX 235.50 ($2.96).

Oxford Nanopore Technologies Price Performance

The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07. The firm’s fifty day moving average price is GBX 142.50 and its 200 day moving average price is GBX 129.63. The stock has a market cap of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80.

Insiders Place Their Bets

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,558,158.40). Insiders have bought a total of 310 shares of company stock valued at $45,010 in the last quarter. 32.62% of the stock is currently owned by insiders.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.